-
-
-
-
-
-
-
Celcuity Inc (CELC) PT Lowered to $155 at Leerink, 'we expect CELC shares to be under pressure given the lofty expectations'
-
-
-
-
-
-
-
Leerink Partners on Agios Pharma (AGIO): NVO's Ph3 trial results likely to pressure shares
-
-
-
-
-
-
-
Damora Therapeutics (DMRA) PT Lowered to $55 at Leerink Partners
-
-
-
-
-
-
-
Regeneron Pharma (REGN) PT Raised to $873 at Leerink Partners
-
-
-
-
-
-
-
Zymeworks (ZYME) PT Raised to $37 at Leerink Partners
-
-
-
-
-
-
-
Leerink Partners Downgrades Merus N.V. (MRUS) to Market Perform
-
-
-
-
-
-
-
Leerink Partners Reiterates Outperform Rating on BeOne Medicines (ONC)
-
173 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


